MARCELO LOPEZ-CLAROS: Open Payments
NPI 1962578047 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,532 in 204 payments from 20 companies in 2025. Trend: 2023 $362 · 2024 $2,560 · 2025 $3,532
Food & beverage: $3,532
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $481 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $455 |
| ABBVIE INC. | 27 | $445 |
| Janssen Pharmaceuticals, Inc | 20 | $351 |
| Axsome Therapeutics, Inc. | 23 | $302 |
| Vanda Pharmaceuticals Inc. | 21 | $257 |
| Alkermes, Inc. | 10 | $224 |
| E.R. Squibb & Sons, L.L.C. | 10 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $188 |
| Bausch Health US, LLC | 9 | $164 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, SPRAVATO, ARISTADA, HETLIOZ, COBENFY.
Industry payments across NC — which companies pay providers there.
